Medicine and Dentistry
Cervical Cancer
16%
Cohort Analysis
66%
Crohn's Disease
17%
Diagnosis
9%
Diseases
7%
Genital Wart
16%
Hazard Ratio
26%
Human Immunodeficiency Virus
16%
Immunosuppressant
10%
Immunosuppressive Drug
16%
Immunosuppressive Treatment
17%
Infection
12%
Infectious Mononucleosis
16%
Inflammatory Bowel Disease
85%
Inflammatory Disorder
16%
Malignant Neoplasm
17%
Meta-Analysis
32%
mRNA Vaccine
16%
Patient with Inflammatory Bowel Disease
7%
Pediatrics
16%
Phenomics
16%
Random Effects Model
5%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Ulcerative Colitis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
68%
Combination Therapy
18%
Crohn's Disease
19%
Disease
7%
Immunosuppressive Agent
17%
Infection
6%
Inflammatory Bowel Disease
100%
Inflammatory Disease
16%
Initiation Factor
16%
Malignant Neoplasm
17%
Mercaptopurine
19%
Mononucleosis
16%
mRNA Vaccine
16%
Random Effects Model
6%
SARS Coronavirus
16%
Tumor Necrosis
18%
Ulcerative Colitis
17%
Uterine Cervix Cancer
16%
Keyphrases
Adjusted Hazard Ratio
9%
Antenatal Clinic
8%
Anti-tumor Necrosis Factor (anti-TNF)
16%
Antibody Profiling
16%
Bidirectional Association
5%
Bowel Dysfunction
5%
Cancer Development
16%
Clinically Significant
5%
Confidence Interval
9%
Crohn's Disease
6%
Disease Mechanisms
5%
Embase
7%
Genitourinary Medicine
8%
Hazard Ratio
16%
Human Immunodeficiency Virus Negative
5%
IBD Diagnosis
5%
IBD Patients
5%
Inflammatory Bowel Disease
40%
Inflammatory Bowel Disease Treatment
16%
MEDLINE
7%
Meta-analysis
32%
Pediatric Onset
21%
Phage Immunoprecipitation Sequencing
10%
Population-based Study
16%
Population-representative
6%
Random Effects Model
7%
Review Analysis
17%
SARS-CoV-2 mRNA Vaccine
16%
Sexual Health Clinic
8%
Subgroup Analysis
5%
Systematic Literature Review
5%
Thiopurines
17%
Ulcerative Colitis
6%
VirScan
16%
